Silvia Park, MD^1*, Kihyun Kim², Jun Ho Jang, MD, PhD^3*, Seok Jin Kim, MD.Ph.D.^3*, Won Seog Kim, M.D. Ph.D.^3*, Chul Won Jung, MD, PhD⁴, Ki Sun Jung^3*, Jinhyun Cho^3*, Kwai Han Yoo, MD^3* and Haa-na Song^3*

¹Department of Medicine, Samsung Medical Center, Sungkyunkwan Univ. School of Medicine, Seoul, South Korea
²Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea
³Samsung Medical Center, Seoul, South Korea
⁴Divison of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Shinsuke Takagi, MD, PhD^1*, Hideki Araoka, MD^2*, Naoyuki Uchida, MD, Ph.D¹, Masahiro Abe, MD^2*, Mitsuhiro Yuasa, MD^1*, Kosei Kageyama, MD^3*, Daisuke Kaji, MD^3*, Aya Nishida, MD^1*, Muneyoshi Kimura, MD^2*, Kazuya Ishiwata, MD^1*, Hisashi Yamamoto, MD^1*, Go Yamamoto, MD, PhD^1*, Yuki Asano-Mori, MD, PhD^1*, Koji Izutsu, MD, PhD^1*, Atsushi Wake, MD, PhD³, Akiko Yoneyama, MD, PhD^2* and Shuichi Taniguchi, MD, PhD¹

¹Department of Hematology, Toranomon Hospital, Tokyo, Japan
²Department of Infectious Disease, Toranomon Hospital, Tokyo, Japan
³Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan

Farah O'Boyle, PhD^1*, Sandra Hing, PhD^2*, Yvonne Harrington^1*, Subarna Chakravorty, PhD, FRCPath^1*, Leena Karnik, MD, FRCPath, MBBS,^3*, Helen New, PhD FRCPath^1*, Anne Bradshaw^4*, Richard Szydlo, PhD^5* and Josu de la Fuente, PhD, FRCP, FRCPI, FRCPCH, FRCPath^1,5

¹Department of Paediatrics, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
²Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
³Department of Paediatrics, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
⁴Centre for Haematology, Hammersmith Hospital, Imperial College NHS Healthcare Trust, London, United Kingdom
⁵Centre for Haematology, Imperial College London, London, United Kingdom

Attaphol Pawarode, MD^1,2, Steven Goldstein, MD^1,2*, Daniel R. Couriel, MD^1,2, Thomas Braun, PhD^3*, John M. Magenau, MD^1,2, Mary Mansour Riwes, DO^1,2, Brian Parkin^1,2, Vedran Radojcic, MD^1,2, David Frame, PharmD^1,4*, Sung Choi, MD¹, James Connelly, MD^1*, John E. Levine, MD, MS¹, Gregory A. Yanik, MD^1* and Pavan Reddy, MD^1,2

¹Blood and Marrow Transplantation Program, University of Michigan, Ann Arbor, MI
²Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI
³Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI
⁴College of Pharmacy, University of Michigan, Ann Arbor, MI

Patrice Chevallier, MD, PhD^1*, Myriam Labopin, MD^2*, Regis Peffault de la Tour, MD, PhD^3*, Bruno Lioure, MD^4*, Jean-Yves Cahn⁵, Anne Huynh, MD^6*, Didier Blaise, MD, PhD⁷, Pascal Turlure, MD^8*, Eric Deconinck⁹, Natacha Maillard, MD^10*, Ibrahim Yakoub-Agha, MD, PhD¹¹, Gaelle Guillerm, MD^12*, Nathalie Fegueux, MD^13*, Nathalie Contentin, MD^14*, Jacques-Olivier Bay, MD, PhD¹⁵, Florence Beckerich, MD^16*, Jean-Henri Bourhis, MD, PhD¹⁷, Marie Y. Detrait, MD¹⁸, Stephane Vigouroux^19*, Sylvie François, MD^20*, Faezeh Legrand, MD^21*, Nicole Raus^22*, Thierry Guillaume, MD, PhD^1* and Mohamad Mohty, MD, PhD²³

¹Department of Hematology, Nantes University Hospital, Nantes, France
²Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
³Department of Hematology, Saint Louis Hospital, Paris, France
⁴Department of Hematology and Oncology, CHU Hautepierre, Strasbourg, France
⁵Clinique Universitaire d'Hématologie, Grenoble University Hospital, Grenoble, France
⁶institut universitaire du cancer, Oncopole, TOULOUSE, France
⁷Programme de Transplantation et Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France
⁸Hematology Department, CHU Limoges, Limoges, France
⁹Hematology, INSERM UMR1098 - CHU Jean Minjoz, Besancon, France
¹⁰Bone Marrow Transplant Unit Clinical Hematology, Hopital La Miletrie, Poitiers, France
¹¹Hematology, CHU de Lille, Lille, France
¹²Department of Hematology and Oncology, CH Augustin Morvan, Brest, France
¹³Department of Hematology, CHU Lapeyronie, Montpellier, France
¹⁴Department of Hematology, Centre Henri Becquerel, Rouen, France
¹⁵Department of Hematology, Service d'Hematologie Clinique et de Therapie Cellulaire, CHU, Universite d'Auvergne, EA7283, CIC501, Clermont-Ferrand, Clermont-Ferrand, France
¹⁶Department of Hematology, CHU Henri Mondor, Creteil, France
¹⁷Division of Hematology, Institut Gustave Roussy, Villejuif, France
¹⁸Hematology, Hopital Edouard Herriot, HCL, Universite Lyon 1, Lyon, France
¹⁹Service d’Hematologie Clinique et Therapie Cellulaire, CHU de Bordeaux, Pessac, France
²⁰CHU Angers, Angers, France
²¹CHU, Nice, France
²²CH Lyon Sud-SFGM-TC, Lyon, France
²³Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France

Omar S. Aljitawi, MD¹, Siddhartha Ganguly, MD², Tara L. Lin, MD³, Shana Palla^4*, Chris Lominska^4*, Qing Yu^4*, Singh Anurag^4*, Sunil Abhyankar, MD³, Dennis Allin^5*, Mary Eapen, MBBS⁶ and Joseph McGuirk, DO²

¹Division of Hematology/Oncology, University of Kansas Medical Center, Kansas City, KS
²Division of Hematology/Oncology and Blood and Marrow Transplantation Program, University of Kansas Medical Center, Kansas City, KS
³University of Kansas Medical Center, Kansas City, KS
⁴University of Kansas Medical Center, Kansas City
⁵Department of Emergency Medicine, University of Kansas Medical Center, Kansas City, KS
⁶Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

Midori Nakagaki, BPharm, MSc, BCOP^1*, Michael Barras, BPharm, GradDipClinPharm, PhD^1,2*, Cameron Curley, MBBS, FRACP, FRCPA^3*, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA³ and Glen A Kennedy, MBBS, FRACP, FRCPA^3,4*

¹Pharmacy Department, Royal Brisbane and Women's Hospital, Brisbane, Australia
²School of Pharmacy, University of Queensland, Brisbane, Australia
³Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia
⁴School of Medicine, University of Queensland, Brisbane, Australia

Roni Tamari, MD¹, Proli Anthony, Pharm-D^2*, Juntig Zheng, MS^3*, Ann A. Jakubowski, MD, PhD^1*, Esperanza B Papadopoulos, MD¹, Doris M Ponce, MD⁴, Sean Devlin, PhD^5*, Craig S. Sauter, MD¹, James W. Young, MD¹, Sergio A. Giralt, MD¹ and H.R. Castro-Malaspina, MD⁴

¹Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York
³Department of Statistics, Memorial Sloan Kettering Cancer Center, New York
⁴Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY
⁵Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY

Goichi Yoshimoto, MD, PhD^1*, Toshihiro Miyamoto, MD, PhD¹, Koji Kato, MD, PhD², Yasuo Mori, MD, PhD^1*, Kenjiro Kamezaki, MD, PhD^1*, Katsuto Takenaka, MD, PhD^1*, Hiromi Iwasaki, MD, PhD³ and Koichi Akashi, MD, PhD¹

¹Kyushu University Hospital, Fukuoka, Japan
²Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
³Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan

Mehrdad Hefazi Torghabeh, MD^1*, Moussab Damlaj, MD², Hassan B Alkhateeb, MD^2*, Raymund Razonable, MD^3*, Aref Al-Kali, MD², Shahrukh K. Hashmi, MD², William J Hogan, MD², Mark R Litzow, MD² and Mrinal M Patnaik, MBBS²

¹Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Department of Infectious Disease, Mayo Clinic, Rochester, MN

Ioannis Batsis, MD^1*, Ioanna Sakellari, MD, PhD^2*, Apostolia Papalexandri^2*, Despina Mallouri^2*, Sofia Charalampidou^2*, Maria Kaliou^2*, Achilleas Afisidis^2*, Eleni Gavriilaki, MD², Varnavas C Constantinou, MD^1*, Evangelia Yannaki, MD³, Panayotis Kaloyannidis, MD^2*, Chrysa Apostolou^2*, Damianos Sotiropoulos, MD², Chrysanthi Vadikolia, MD^2*, Christos Smias, MD^2* and Achilles Anagnostopoulos⁴

¹Hematology - BMT Unit, George Papanicolaou General Hospital, Thessaloniki, Greece
²Hematology-BMT Unit, George Papanicolaou Hospital, Thessaloniki, Greece
³Haematology-BMT unit, George Papanicolaou Hospital, Thessaloniki, Greece
⁴Hematology-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece

Takayuki Takachi, MD, PhD^1*, Yuki Arakawa, MD^2*, Hiroyoshi Nakamura, PhD^3*, Tomoyuki Watanabe, PhD^4*, Yuki Aoki, MD, PhD^5*, Junjiro Ohshima, MD, PhD^6*, Yoshihiro Takahashi, MD, PhD^7*, Masahiro Hirayama, MD, PhD^8*, Takako Miyamura, MD, PhD^9*, Kanji Sugita, MD, PhD¹⁰, Katsuyoshi Koh, MD, PhD^2*, Keizo Horibe, MD, PhD¹¹, Eiichi Ishii, MD, PhD¹² and Daisuke Tomizawa, MD, PhD¹³

¹Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
²Department of Hematology and Oncology, Saitama Children's Medical Center, Saitama, Japan
³Department of Pharmacy, International University of Health and Welfare Mita Hospital, Tokyo, Japan
⁴Department of Nutritional Science, Faculty of Psychological and Physical Science, Aichi Gakuin University, Nisshin, Japan
⁵Department of Pediatric Oncology, National Cancer Center, Tokyo, Japan
⁶Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
⁷Department of Pediatrics, Aomori Prefectural Central Hospital, Aomori, Japan
⁸Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan
⁹Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan
¹⁰Pediatrics, School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan
¹¹Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
¹²Pediatrics, Ehime University, Toon, Japan
¹³Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan

Amado J Karduss-Urueta, MD¹, Giovanni Ruiz, MD^1*, Rosendo Perez^1*, Alejo Jimenez, MD^1*, Angelica Cardona, Tech^2*, Gloria Suarez, MD^1*, Luis R Gomez, MD^1* and Pedro Reyes, MD^1*

¹Bone Marrow Transplant Program, Instituto de Cancerologia, Medellin, Colombia
²Research Unit, Instituto de Cancerologia, Medellin, Colombia

Jennifer M. Beswick, BHSc, MD^1*, Elizabeth Shin^1*, Jieun Uhm, MD², Fotios V. Michelis, MD, PhD³, Auro Viswabandya, MD, DM³, Jeffrey H. Lipton, MD, PhD³, Hans A. Messner, M.D./Ph.D², Theodore Marras, MD, MSc^4* and Dennis Dong Hwan Kim, MD, PhD⁵

¹University of Toronto, Toronto, ON, Canada
²Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
³Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
⁴Department of Respirology, University of Toronto, University Health Network, Toronto, ON, Canada
⁵Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Liisa Volin, MD, PhD, Riitta Niittyvuopio, MD, PhD^*, Jouni Heiskanen, MD^*, Vesa Lindstrom, MD^*, Leila Sahlstedt, MD, PhD^* and Tapani Ruutu, MD, PhD

Stem Cell Transplantation Unit, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland

Daniela Heidenreich^*, Eleonore Muetzel^*, Sebastian Kreil^*, Florian Nolte^*, Melanie Faust^*, Mohamad Jawhar^*, Anna Hecht^*, Wolf-Karsten Hofmann and Stefan A. Klein

III. Medizinische Klinik, Hämatologie und Onkologie, Universitätsmedizin Mannheim, Mannheim, Germany

Moaath Mustafa Ali, MD^1*, Donna M Abounader^2*, Lisa A. Rybicki, MS^3*, Melissa A Yurch^2*, Jamie Starn, RN, BSN^2*, Christina Ferraro, RN, BSN^2*, Victoria Winslow, RN, BSN^2*, Betty K. Hamilton, MD^2,4, Aaron T. Gerds, MD, MS⁵, Hien Liu, MD^2*, Robert Dean², Brian T. Hill, MD. PhD², Brad Pohlman, MD², Steven Andresen, DO^2*, Rabi Hanna, MD⁶, Matt Kalaycio, MD⁵, Brian J. Bolwell, MD², Navneet S. Majhail, MD, MS² and Ronald Sobecks, MD²

¹Internal Medicine, Cleveland Clinic, Cleveland, OH
²Blood and Marrow Transplant, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH
⁴Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁵Leukemia Program, Cleveland Clinic, Cleveland, OH
⁶Pediatric Hematology/Oncology, Cleveland Clinic, Cleveland, OH

Sita D. Bhella, MD¹, Elizabeth Shin^2*, Marc Poch Martell, MD^3*, Jieun Uhm, MD⁴, Fotios V. Michelis, MD, PhD³, Auro Viswabandya, MD, DM³, Jeffrey H. Lipton, MD, PhD³, Hans A. Messner, M.D./Ph.D⁵ and Dennis Dong Hwan Kim, MD, PhD⁶

¹Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
²University of Toronto, Toronto, ON, Canada
³Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
⁴Department of Hematology & Oncology, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, South Korea
⁵Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Alexis Caulier^1*, Jordan Gauthier, MD, MSc^2*, Marie Robin, MD, PhD³, Patrice Chevalier^4*, Yves Beguin, MD, PhD⁵, Hélène Labussière-Wallet, MD^6*, Stephane Vigouroux^7*, Jean-Yves Cahn, MD⁸, Stéphanie Nguyen^9*, Felipe Suarez, MD, PhD¹⁰, Anne Huynh, MD^11*, Norbert Ifrah, MD¹², Mohamad Mohty, MD¹³, Eric Deconinck, MD, PhD¹⁴, Gandhi Damaj, MD, PhD¹⁵ and Ibrahim Yakoub-Agha, MD, PhD¹⁶

¹Hematology and cellular therapy, CHU Amiens Sud, Amiens Cedex 1, France
²Secteur allogreffe de cellules souches hématopoïétiques, CHRU Lille, Lille, France
³Hematology - Bone Marrow Transplantation, Saint-Louis Hospital, Paris, France
⁴CHU Nantes, Nantes, France
⁵Division of Hematology, Department of Medicine, University and CHU of Liège, Liège, Belgium
⁶Hematology department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France
⁷Service d’Hematologie Clinique et Therapie Cellulaire, CHU de Bordeaux, Pessac, France
⁸Hematology Department, CHU de Grenoble, Grenoble, France
⁹Hôpital de la Pitié Salpêtrière – Assistance Publique-Hôpitaux de Paris, Paris, France
¹⁰Hematologie, Hopital Necker, Assistance Publique-Hopitaux de Paris French Ref. Ctr. for Prima, Paris, France
¹¹Institut Universitaire du cancer, Oncopole IUCT, Toulouse, France
¹²PRES LUNAM, CHU Angers service des Maladies du Sang et INSERM U 892, Angers, France
¹³Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
¹⁴Hematology, INSERM UMR645 - CHU Jean Minjoz, Besançon, France
¹⁵Hematology Department, CHU Caen, Caen, France
¹⁶Maladies du Sang, UAM Allogreffes de CSH - EA2686, Lille, France

Nosha Farhadfar, MD^*, Damlaj Moussab, MD^*, Ajoy L. Dias, MD^*, Hassan B Alkhateeb, MD^*, Mark R Litzow, MD, Shahrukh K. Hashmi, MD, Mrinal M Patnaik, MBBS and William J Hogan, MBChB

Division of Hematology, Mayo Clinic, Rochester, MN

Rocco Pastano, MD^*, Giovanna Andreola, MD^*, Federica Gigli, MD^*, Simona Sammassimo, MD^*, Mara Negri^*, Liptrott Jayne Sarah^* and Corrado Tarella, MD^*

European Institute of Oncology, Division of Hematoncology, Milan, Italy

Tomonori Nakazato, Chisako Ito^*, Kengo Shimazaki^*, Hideki Arakaki^* and Yoshinobu Aisa^*

Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan